This new issue of Stanford Medicine magazine reports on emerging research and innovative treatments to improve mental health.

A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in pioneering research, creative teaching protocols and effective clinical therapies.

In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone’s ability to fend off more potent opioids, with promising results in mice.

Students were enouraged to adopt optimism, listen to their muse and dance to their own beat.

Researchers have identified six subtypes of depression, paving the way toward personalized treatment.

A class of blood pressure drugs appears to reduce the chance of developing epilepsy.

The technology can be trained by pathologists, giving them personalized assistance in identifying cells that might indicate diseases such as cancer or endometritis